Wayne Holman
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 8
- SARS-CoV-2 detection and testing 1
-
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Wendy Painter (6 shared papers)Jim A. Bush (2 shared papers)George R. Painter (3 shared papers)Firas Almazedi (1 shared paper)Merribeth J. Morin (1 shared paper)Cameron R. Wolfe (2 shared papers)David Alain Wohl (1 shared paper)Lei Fang (1 shared paper)
- Journals
- Science Translational Medicine (1 paper)Clinical Infectious Diseases (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Clinical and Translational Science (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Wayne Holman
8 papers receiving 945 citations
Wayne Holman's Hit Papers
Peers
Comparison fields: 5 of 63
- Infectious Diseases 755
- Pharmacology 39
- Computational Theory and Mathematics 58
- Analytical Chemistry 30
- Modeling and Simulation 13
Countries citing papers authored by Wayne Holman
This map shows the geographic impact of Wayne Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Holman more than expected).
Fields of papers citing papers by Wayne Holman
This network shows the impact of papers produced by Wayne Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Holman. The network helps show where Wayne Holman may publish in the future.
Co-authors
The 25 scholars most cited alongside Wayne Holman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus Hit paper breakdown → | 2021 | 413 |
| 2 | Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2 Hit paper breakdown → | 2021 | 323 |
| 3 | 2021 | 97 | |
| 4 | 2022 | 65 | |
| 5 | 2021 | 45 | |
| 6 | 2022 | 17 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 2 | |
| 9 | 2025 | 0 |
About Wayne Holman
Wayne Holman is a scholar working on Infectious Diseases, Pharmacology, Pediatrics, Perinatology and Child Health, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 970 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Infectious Diseases (755 citations), Pharmacology (39 citations), Computational Theory and Mathematics (58 citations), Analytical Chemistry (30 citations) and Modeling and Simulation (13 citations). Wayne Holman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Wendy Painter, Jim A. Bush, George R. Painter, Firas Almazedi, Merribeth J. Morin, Cameron R. Wolfe, David Alain Wohl, Lei Fang, Ralph Steven Baric and Robert W. Coombs. Their work appears in journals such as Science Translational Medicine, Clinical Infectious Diseases, CPT Pharmacometrics & Systems Pharmacology, Clinical and Translational Science and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.